Showing results (1481-1490 of 1,838) with videos related to
Sort By:
Pageof 184
Metabolites|February 6, 2020
General Guidelines for Sample Preparation Strategies in HR-µMAS NMR-based Metabolomics of Microscopic SpecimensCovadonga Lucas-Torres, Thierry Bernard, Gaspard Huber, et al.Journal of Neuro-Oncology|February 20, 2008
Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?Amerigo Boiardi, Antonio Silvani, Marica Eoli, et al.International Journal of Molecular Sciences|August 23, 2019
Anti-Apoptotic and Anti-Oxidant Proteins in Glioblastomas: Immunohistochemical Expression of Beclin and DJ-1 and Its Correlation with PrognosisElia Guadagno, Giorgio Borrelli, Sara Pignatiello, et al.Cardiovascular Research|March 16, 2019
Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stressMarion Laudette, Antonio Coluccia, Yannis Sainte-Marie, et al.Journal of Pharmaceutical Sciences|February 3, 2024
Topical Tacrolimus and Mycophenolic Acid Therapy Synergizes with Low Dose Systemic Immunosuppression to Sustain Vascularized Composite Allograft SurvivalFiruz G Feturi, Wensheng Zhang, Vasil E Erbas, et al.Journal of Neurophysiology|December 21, 2022
Cortical reintegration after facial allotransplantationKia M Washington, Mario G Solari, Rami R Zanoun, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|March 1, 2019
Insight of the Metal-Ligand Interaction in f-Element Complexes by Paramagnetic NMR SpectroscopyMatthieu Autillo, Laetitia Guerin, Thomas Dumas, et al.Frontiers in Immunology|May 2, 2015
Effects of immunosuppressive drugs on viability and susceptibility of adipose- and bone marrow-derived mesenchymal stem cellsWakako Tsuji, Jonas T Schnider, Meghan M McLaughlin, et al.Oral Diseases|February 27, 2016
Pharmacological targeting of histamine H4 receptor in periodontal diseaseJ P Prestifilippo, J Fernández-Solari, D J Martinel Lamas, et al.Plos Pathogens|October 10, 2022
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entryLalita Priyamvada, Wouter W Kallemeijn, Monica Faronato, et al.Pageof 184